Article in Antibiotics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Anwar Al SouheilDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut 1107 2809, Lebanon.ORCID 0000-0002-1329-9326
Hadi HusseinDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.ORCID 0009-0000-9146-9397
Ziad JabbourDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.ORCID 0009-0005-9623-3478
Sara BaradaDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
Jose-Rita GergesDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
Ghada DerbajDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
Abdallah KurdiDepartment of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.ORCID 0000-0002-8321-4025
Hassan Jamil KazmaLaboratory Department, Hammoud Hospital University Medical Center, Saida 11-2644, Lebanon.
Ali Hasan NajemLaboratory Department, Lebanese Italian Hospital, Tyre 1645, Lebanon.
Abdallah MedlejMolecular Biology Unit, Laboratory Department, Sheikh Ragheb Harb University Hospital, Nabatieh 11-2064, Lebanon.ORCID 0000-0002-8820-7238
Wael ZorkotFaculty of Public Health, Lebanese University, Beirut 14-6573, Lebanon.ORCID 0000-0002-4261-6474
Rana El HajjDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut 1107 2809, Lebanon.ORCID 0000-0001-9125-5137
Mahmoud I KhalilDepartment of Biological Sciences, Faculty of Science, Beirut Arab University, Beirut 1107 2809, Lebanon.ORCID 0000-0001-7629-4357
Ghassan M MatarDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
Antoine Abou FayadDepartment of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.ORCID 0000-0002-7516-7919
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Molecular Epidemiological Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Southern Lebanon. · full record | OpenQuestion